HLA-E and neoplasm: Studies from our group and others supported an immunosuppressive potential of this expression, through engagement of the CD94/NKG2A inhibitory NKR on cytotoxic cells (NK and CD8 TIL) by tumor cell membrane HLA-E [13]–[16].